top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
Assessment of the CDC Anthrax Vaccine Safety and Efficacy Research Program [[electronic resource]]
Assessment of the CDC Anthrax Vaccine Safety and Efficacy Research Program [[electronic resource]]
Autore Staff Institute of Medicine
Pubbl/distr/stampa Washington, : National Academies Press, 2002
Descrizione fisica 1 online resource (179 p.)
Disciplina 615
Soggetto topico Anthrax -- Vaccination
Public health
Anthrax - Vaccination - Research - United States
Bacterial Vaccines
Evaluation Studies as Topic
Health Care Evaluation Mechanisms
Quality of Health Care
Bacillaceae Infections
Investigative Techniques
Vaccines
Health Services Administration
Gram-Positive Bacterial Infections
Bacterial Infections
Health Care Quality, Access, and Evaluation
Health Care
Analytical, Diagnostic and Therapeutic Techniques and Equipment
Biological Products
Complex Mixtures
Bacterial Infections and Mycoses
Chemicals and Drugs
Diseases
Program Evaluation
Drug Evaluation
Anthrax
Anthrax Vaccines
Public Health
Health & Biological Sciences
Communicable Diseases
Soggetto genere / forma Electronic books.
ISBN 0-309-50374-4
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto ""Front Matter""; ""Preface""; ""Reviewers""; ""Contents""; ""Figures, Tables, and Boxes""; ""Abbreviations and Acronyms""; ""Executive Summary""; ""1 Introduction""; ""2 Background""; ""3 The CDC Anthrax Vaccine Research Plan""; ""4 Proposed Studies on the Efficacy of the Anthrax Vaccine""; ""5 Proposed Studies on the Safety of the Anthrax Vaccine""; ""6 Proposed Studies on the Acceptability of the Anthrax Vaccine""; ""7 Summary Assessment of the CDC Anthrax Vaccine Research Plan""; ""Appendix A Biographical Sketches""; ""Appendix B Information-Gathering Meeting Agendas""
""Appendix C Anthrax Vaccine Safety & Efficacy Research Plan""""Appendix D Food and Drug Administration Final Rule: New Drug and Biological Drug Products; Evidence Needed to Demonstrate Effectiveness of New Drugs When Human Efficacy Studies Are Not Ethical or Feasible""; ""Appendix E Department of Defense Memorandum: Reintroduction of the Anthrax Vaccine Immunization Program""; ""Appendix F Institute of Medicine: CDC Anthrax Vaccine Safety & Efficacy Research Program. Interim Report Findings and Recommendations1""
""Appendix G Institute of Medicine: The Anthrax Vaccine: Is It Safe? Does It Work? Findings and Recommendations1""
Record Nr. UNINA-9910455868803321
Staff Institute of Medicine  
Washington, : National Academies Press, 2002
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Assessment of the CDC Anthrax vaccine safety and efficacy research program [[electronic resource]]
Assessment of the CDC Anthrax vaccine safety and efficacy research program [[electronic resource]]
Autore Staff Institute of Medicine
Pubbl/distr/stampa Washington, : National Academies Press, 2002
Descrizione fisica 1 online resource (179 p.)
Disciplina 615
Soggetto topico Anthrax -- Vaccination
Public health
Anthrax - Vaccination - Research - United States
Bacterial Vaccines
Evaluation Studies as Topic
Health Care Evaluation Mechanisms
Quality of Health Care
Bacillaceae Infections
Investigative Techniques
Vaccines
Health Services Administration
Gram-Positive Bacterial Infections
Bacterial Infections
Health Care Quality, Access, and Evaluation
Health Care
Biological Products
Complex Mixtures
Bacterial Infections and Mycoses
Diseases
Program Evaluation
Drug Evaluation
Anthrax
Anthrax Vaccines
Public Health
Health & Biological Sciences
Communicable Diseases
ISBN 0-309-50374-4
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto ""Front Matter""; ""Preface""; ""Reviewers""; ""Contents""; ""Figures, Tables, and Boxes""; ""Abbreviations and Acronyms""; ""Executive Summary""; ""1 Introduction""; ""2 Background""; ""3 The CDC Anthrax Vaccine Research Plan""; ""4 Proposed Studies on the Efficacy of the Anthrax Vaccine""; ""5 Proposed Studies on the Safety of the Anthrax Vaccine""; ""6 Proposed Studies on the Acceptability of the Anthrax Vaccine""; ""7 Summary Assessment of the CDC Anthrax Vaccine Research Plan""; ""Appendix A Biographical Sketches""; ""Appendix B Information-Gathering Meeting Agendas""
""Appendix C Anthrax Vaccine Safety & Efficacy Research Plan""""Appendix D Food and Drug Administration Final Rule: New Drug and Biological Drug Products; Evidence Needed to Demonstrate Effectiveness of New Drugs When Human Efficacy Studies Are Not Ethical or Feasible""; ""Appendix E Department of Defense Memorandum: Reintroduction of the Anthrax Vaccine Immunization Program""; ""Appendix F Institute of Medicine: CDC Anthrax Vaccine Safety & Efficacy Research Program. Interim Report Findings and Recommendations1""
""Appendix G Institute of Medicine: The Anthrax Vaccine: Is It Safe? Does It Work? Findings and Recommendations1""
Record Nr. UNINA-9910780301103321
Staff Institute of Medicine  
Washington, : National Academies Press, 2002
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui